• 1

    The goal

    Developing of competitive and high-performance innovation center within Tomsk agglomeration boarders where high value-added industry and high-quality human resources are concentrated and advanced technologies are created in order to increase the quality of life and implement new model of economic growth.

  • 2


    «Advanced industry», «Science and education», «Technological innovations, new businesses», «Smart and handy city», «Business environment»

  • 3


    RUB 250 bln – investment gap. Confirmed extra-budgetary resources amounts to 65%.

  • 4


    12 federal ministries, 6 Tomsk universities, 5 national corporations, 400 small and medium innovation companies and manufacturing plants

  • 5


    INO Tomsk project synchronizes over 50 federal instruments and initiatives of different federal ministries and agencies.

  • 6


    65 actions included in roadmap help to involve stakeholders in INO Tomsk project.

  • 7


    6 types of areas within Tomsk agglomeration are developed according to INO Tomsk project: industrial, innovation, research and educational, historical and cultural, medical and sport parks.

  • 8


    INO Tomsk project is based on 6 innovation territorial clusters: petrochemical cluster, cluster of nuclear technologies, timber and pharmaceutical clusters, cluster of medical equipment and IT, cluster of wildlife resources, and cluster of hard-to-recover resources.

  • 9


    160 thousands of highly-efficient workplaces will be created before 2020 as a result of INO Tomsk project implementation.

  • 10


    Over 100 industrial, research and educational, social and infrastructure projects are implemented within INO Tomsk.

Medicine of the Future is not so Distant

22 February 2012 19:00

The technological platform is already yielding tangible results.

Our region will receive over 2.5 billion rubles this year due to the technological platform “Medicine of the Future”: federal support is guaranteed to eleven priority projects based on “breakthrough” technologies.  

What result is expected? We will get the experience of rapid distribution of cutting-edge technologies in medical and pharmaceutical sectors, and the most important result is that unique high-tech products and services providing for a significant improvement of living standards will appear in the market.   

So, what areas does it cover? First of all, we should point out a large network project – three Tomsk universities (TSU, TPU and SSMU) as well as an enterprise producing glyoxal are working to create a technology to produce modern biodegradable surgical sutures. As a result of this project the first Russian plant producing absorbable glyoxal-based sutures (surpassing all other sutures in fineness) will appear in Tomsk. According to experts, the market for such products is huge, but until recently there has not been such industrial production in Russia. 

– For the first time we have got orders for research and developments from manufacturing partners, – sais professor Lyudmila Ogorodova, Deputy of the RF State Duma, Head of the Technological Platform “ Medicine of the Future”.- Siberian State Medical University has not got such practice before that. Now SSMU will take part in the development of a “road map” for projects based on glyoxal production in Tomsk. Our business-partner has designed launching of several similar projects: apart from the development of the unique suture there will be also the development of antituberculosis, anticancer medicines and disinfecting medical solutions.

Siberian State Medical University has also got the first large project for the development of sets for immunological and molecular genetic diagnosis of opisthorchiasis. The University is the project coordinator. The project costs 360 million rubles including budgetary support and funds of investor – manufacturing partner. 

Immanuel Kant Baltic Federal University, the National Research Center Kurchatovsky Institute, Center Bioengineering, the Institute of Cytology and Genetics, SB RAS are executing the project. As a result, in 2013 medical researchers will create a highly sensitive and specific test for opisthorchiasis diagnosis.    

Tomsk researchers have managed to become participants of another important program – “Pharma-2020”. 

- We have got five projects on medicine development – preclinical studies of drugs, – says Lyudmila Ogorodova. – the Institute of Pharmacology has received two of them, SSMU has got one project as well as the Scientific-Research Institute of Oncology and the Scientific-Research Institute of Cardiology in cooperation with TPU

A center of excellence will appear on the basis of the Institute of Pharmacology. There are only two similar scientific centers in the country – in Moscow and Tomsk. Tomsk innovative pharmacology will be oriented at the production of drugs to substitute imported medicines, which will significantly reduce the price of medications (national analogues always cost less than foreign pills) and besides, it will protect consumers from pirate medical goods. 

An international center for preclinical studies and development of medicines will be built in Tomsk. An international standard of drug design and development is the guarantee of safety and high efficiency as well as the straight way to foreign markets. The center will include a nursery and vivarium for laboratory animals and a toxicology laboratory.    

As the designers of the technological platform “Medicine of the Future” say, the federal support will be channeled not only into drug designing including innovative drugs but also into the development of unique devices and new materials. So, the Institute of Strength Physics and Materials Science of the Siberian Branch of the Russian Academy of Sciences have received federal financing for the development and production of biocompatible materials including structures for implantation and replacement of moving skeletal system elements.  

- Today, using such federal tool of innovative development as a technological platform we have made sure that tangible results may be achieved, – continues Lyudmila Ogorodova. – As soon as in the nearest future, I am sure, R&Ds will result in some particular products; the infrastructure and environment will be developed to eliminate foot-dragging and bureaucratic red-tape on the way of project implementation from the researcher through manufacturing to the market.   

What gives such confidence? The main goal set by designers of the technological platform “Medicine of the Future” can be stated in the following way: to create a frame for efficient collaboration between business, science and state to develop medical and pharmaceutical sectors of economy. A strict top-down command structure had been functioning before the platform appeared. So, universities of the Ministry of Education collaborated only with each other as well as universities of the Ministry of Healthcare since all federal support programs for projects were aimed only at some particular areas and sectors). Nowadays, instead of a top-down structure we are developing network collaboration based on the integrated project. Within the framework of the platform interactions of all participants at different stages will be coordinated. Besides, we plan to seek investors or state support for them. So, the project defined as promising for the country will not finish after one stage but will end up with full cycle. And the platform starts accomplishing the task. Suffice it to say that 174 projects have been implemented within the platform now, 24 of them were development works that is projects aimed at the establishment of pilot plant production.     

Who shapes and how do they shape national priorities of medical development, plan long-term scientific, innovation and industrial strategic programs? The expert community that is formed with the help of such tool as the technological platform, considers Lyudmila Ogorodova.  When choosing priorities risks are eliminated due to the good analytic and forecasting base.     SSMU has got financing for the coordination of industrial forecasting centers in the area of “Life Sciences”. Within this project SSMU is planning to open eight centers based on research and federal universities of Russia to monitor scientific, technological, manufacturing situation in their competence-specific areas.

196 organizations have signed the memorandum on participation in the technological platform “Medicine of the Future” so far. 74 of them are manufacturing enterprises. However, the number of participants increases day by day. So, another 53 organizations have applied for participation in the platform.     

Next stage is the registration of a non-profit partnership and executive board of directors.

Source: Krasnoe Znamya